Phillips Ronald L 4

4 · SYSCO CORP · Filed Jul 24, 2025

Form 4

Period: 2025-07-23

EVP and CHRO

Transactions

Sale
Common Stock
2025-07-23$81.00/sh−6,286$509,166→ 30,234.963 total
Exercise/Conversion
Common Stock
2025-07-23$74.85/sh+6,286$470,507→ 67,840.963 total
Sale
Common Stock
2025-07-23$81.00/sh−962$77,922→ 36,520.963 total
Exercise/Conversion
Stock Options (Right to buy)
2025-07-23−6,286→ 12,571 total
Exercise: $74.85Exp: 2033-08-09→ Common Stock (6,286 underlying)
Exercise/Conversion
Common Stock
2025-07-23$69.95/sh+962$67,292→ 61,554.963 total
Sale
Common Stock
2025-07-23$81.00/sh−30,358$2,458,998→ 37,482.963 total
Exercise/Conversion
Stock Options (Right to buy)
2025-07-23−30,358→ 0 total
Exercise: $76.94Exp: 2031-08-18→ Common Stock (30,358 underlying)
Exercise/Conversion
Common Stock
2025-07-23$76.94/sh+30,358$2,335,745→ 60,592.963 total
Exercise/Conversion
Stock Options (Right to buy)
2025-07-23−962→ 1,922 total
Exercise: $69.95Exp: 2033-09-10→ Common Stock (962 underlying)

Footnotes (3)

[F1]The exercises and sales were effected pursuant to a Rule 10b5-1 trading plan.
[F2]Options are fully exercisable.
[F3]Options granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan.

Documents

4 files